[Form 4] Workhorse Group, Inc Insider Trading Activity
Richard F. Dauch, who serves as Chief Executive Officer and a director of Workhorse Group Inc. (WKHS), was granted 60,607 restricted stock units (RSUs) on 08/18/2025. Each RSU represents the contingent right to one share of common stock that vests on 02/18/2026. The company’s board may elect to settle vested RSUs in cash instead of shares. Following the grant, the reporting person beneficially owns 60,607 RSUs (direct).
- Alignment of interests: RSUs tie the CEO’s compensation to company equity performance through vesting.
- Retention incentive: A one-year vesting schedule supports short-term retention of the CEO through 02/18/2026.
- Potential dilution or cash cost: Board discretion to settle in cash or shares could either dilute existing shareholders or create cash outflows.
- Limited disclosure of valuation or performance criteria: Filing does not state grant value or performance conditions, making impact assessment incomplete.
Insights
TL;DR: A routine executive equity grant to align CEO incentives with shareholder outcomes; settlement flexibility could affect dilution.
The RSU award to the CEO is a standard retention and incentive tool that ties compensation to future share performance through a fixed vesting date of 02/18/2026. The board’s discretion to settle in cash introduces an alternative cost profile for the company: cash settlement avoids share dilution but can create near-term cash obligations. The disclosure shows direct beneficial ownership of 60,607 RSUs but does not provide prior holdings, grant valuation, or vesting conditions beyond the single vesting date, limiting assessment of total compensation impact.
TL;DR: Material for compensation monitoring but not a definitive signal on performance expectations or governance changes.
This grant size (60,607 RSUs) is disclosed as a single, time-based tranche vesting on 02/18/2026, indicating a one-year retention horizon. The form states each RSU equals one share upon vesting and may be cash-settled at the board’s option, which affects whether dilution or cash expense will ultimately occur. The filing lacks fair-value, grant-date valuation, prior grant comparison, or payout triggers tied to performance, so the award appears time-based rather than performance-contingent.